By
Ronald Baker, PhD
During
the past two weeks, HIV and Hepatitis.com has posted previews and reviews
of selected studies from the 41st EASL, which took place in Vienna, Austria, April
26-30, 2006. Following is a collection of articles on data from selected studies
presented at the conference as well as links to the abstracts of several dozen
additional studies from the 2006 annual EASL meeting.
Unless otherwise
stated, all references are to the Program and abstracts of the 41st Annual Meeting
of the European Association for the Study of the Liver (41st EASL). April 26 -
30, 2006; Vienna, Austria.
Treatment
for Hepatitis C
Treatment for Chronic Hepatitis C: FDA-approved
Therapies
Treatment for Chronic Hepatitis C: Experimental
Treatments
Liver Tumors
(Natural History, Epidemiology, Diagnosis, and Management)
Liver
Transplantation
Diagnostics:
Hepatitis B and Hepatitis C
Treatment
for Hepatitis B
Treatment
for Chronic Hepatitis B: FDA-approved Therapies
-
Adefovir (Hepsera)
-
Entecavir (Baraclude)
-
Peginterferon alfa-2a (Pegasys)
-
Lamivudine (Epivir-HBV)
Treatment for
Chronic Hepatitis B: Experimental Mono- and Combination Therapies
-
Monotherapy Studies
-
Combination Therapy Studies
Experimental Treatments:
Miscellaneous
Liver Tumors (Natural
History, Epidemiology, Diagnosis, and Management)
Liver
Transplantation
Diagnostics:
Hepatitis B and Hepatitis C
HIV-HCV
Coinfection
Treatment
for HIV-HCV Coinfection
Library
of Slides and Posters
Library
of Slides and Posters from EASL 2006
-
Hepatitis C
-
Hepatitis B
-
HIV-HCV Coinfection
| 
